Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

EVP and CSO

President and CEO

Chief Financial Officer

Chief Medical Officer

Chief Operating Officer

President, CEO and CFO

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidates include INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation; and INB-400, which is in Phase 2 clinical trial to treat newly diagnosed GBM. It also develops INB-300, INB-410, and INB-500 that are in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T ce...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-12-13	Premium	acquired	Premium	Premium	Premium	-
2023-12-13	Premium	acquired	Premium	Premium	Premium	-
2023-12-13	Premium	acquired	Premium	Premium	Premium	-
2023-12-13	Premium	acquired	Premium	Premium	Premium	EVP and CSO
2023-12-13	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-12-13	Premium	acquired	Premium	Premium	Premium	-
2023-12-13	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-12-13	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-12-13	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2023-09-13	Premium	bought	Premium	Premium	Premium	-
2023-08-25	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2023-08-24	Premium	bought	Premium	Premium	Premium	President and CEO
2023-07-28	Premium	sold	Premium	Premium	Premium	-
2022-12-12	Premium	bought	Premium	Premium	Premium	-
2022-12-12	Premium	bought	Premium	Premium	Premium	-
2022-09-28	Premium	bought	Premium	Premium	Premium	-
2022-09-28	Premium	bought	Premium	Premium	Premium	-
2022-08-29	Premium	bought	Premium	Premium	Premium	-
2022-08-29	Premium	bought	Premium	Premium	Premium	-
2022-08-26	Premium	bought	Premium	Premium	Premium	-
2022-08-26	Premium	bought	Premium	Premium	Premium	-
2022-08-17	Premium	bought	Premium	Premium	Premium	-
2022-08-17	Premium	bought	Premium	Premium	Premium	-
2022-08-16	Premium	bought	Premium	Premium	Premium	-
2022-08-16	Premium	bought	Premium	Premium	Premium	-

INAB - IN8bio Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for INAB